|
SYNJ2BP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66533453693773E-15 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62747593179802E-12 |
| Normal-vs-Stage2 |
1.53809964764662E-10 |
| Normal-vs-Stage3 |
7.42229611105927E-11 |
| Normal-vs-Stage4 |
3.70899977397698E-11 |
| Stage1-vs-Stage2 |
4.212800E-01 |
| Stage1-vs-Stage3 |
7.316500E-02 |
| Stage1-vs-Stage4 |
7.313900E-02 |
| Stage2-vs-Stage3 |
5.141400E-01 |
| Stage2-vs-Stage4 |
2.329800E-01 |
| Stage3-vs-Stage4 |
5.933800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62503344114384E-12 |
| Normal-vs-AfricanAmerican |
3.53095330751785E-12 |
| Normal-vs-Asian |
1.58980000275477E-08 |
| Caucasian-vs-AfricanAmerican |
3.692200E-01 |
| Caucasian-vs-Asian |
2.005000E-01 |
| AfricanAmerican-vs-Asian |
1.197220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-15 |
| Normal-vs-Female |
1.66289204628356E-12 |
| Male-vs-Female |
9.382200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.0724754417879E-13 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
1.71274106008923E-12 |
| Normal-vs-Extreme_Obese |
3.801900E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.630200E-01 |
| Normal_Weight-vs-Obese |
3.512200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.675200E-01 |
| Extreme_Weight-vs-Obese |
3.073000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.675400E-01 |
| Obese-vs-Extreme_Obese |
4.357600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.012500166515E-10 |
| Normal-vs-Age(41-60Yrs) |
1.64934732538313E-12 |
| Normal-vs-Age(61-80Yrs) |
2.22044604925031E-16 |
| Normal-vs-Age(81-100Yrs) |
1.25889965119086E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.598800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.258000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.514000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.796570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.442350E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.775800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.64290803184031E-12 |
| Normal-VS-Type2 PRCC |
<1E-12 |
| Normal-VS-KIRP CIMP |
3.46870310252712E-11 |
| Normal-VS-Unclassified PRCC |
1.26139999556685E-08 |
| Type1 PRCC-VS-Type2 PRCC |
6.024900E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.122900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.534600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.786600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.224980E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.007990E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
8.97060203897126E-14 |
| Normal-vs-N2 |
3.36649996768301E-09 |
| N0-vs-N1 |
9.038000E-01 |
| N0-vs-N2 |
3.285800E-02 |
| N1-vs-N2 |
3.612100E-02 |
|
|
